Clinical Impact of the Expanded BioFire Blood Culture Identification 2 Panel in a U.S. Children’s Hospital
Kelly Graff, Claire Palmer, Toraj Anarestani, Darcy Velasquez, Stacey Hamilton, Kristin Pretty, Sarah K. Parker, Samuel R. Dominguez
Abstract
C and SCCmec right extremity junction (MREJ) target for better Staphylococcus aureus and coagulase-negative Staphylococcus (CoNS) differentiation. Most importantly, it provides additional clinical impact with the potential to decrease the time to optimal antimicrobial therapy compared to the BioFire BCID panel, with likely further impact at institutions with a higher prevalence of Gram-negative resistance.
Topics & Concepts
Identification (biology)Panel dataEconometricsMathematicsBiologyBotanyBacterial Identification and Susceptibility TestingAntimicrobial Resistance in StaphylococcusInfective Endocarditis Diagnosis and Management